BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21526434)

  • 1. Molecular dynamics as an approach to study prion protein misfolding and the effect of pathogenic mutations.
    van der Kamp MW; Daggett V
    Top Curr Chem; 2011; 305():169-97. PubMed ID: 21526434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural facets of disease-linked human prion protein mutants: a molecular dynamic study.
    Rossetti G; Giachin G; Legname G; Carloni P
    Proteins; 2010 Dec; 78(16):3270-80. PubMed ID: 20806222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation.
    Biljan I; Ilc G; Giachin G; Raspadori A; Zhukov I; Plavec J; Legname G
    J Mol Biol; 2011 Sep; 412(4):660-73. PubMed ID: 21839748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein misfolding and prion diseases.
    Cohen FE
    J Mol Biol; 1999 Oct; 293(2):313-20. PubMed ID: 10550211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the pathogenic mutations T188K/R/A on the structural stability and misfolding of human prion protein: insight from molecular dynamics simulations.
    Guo J; Ning L; Ren H; Liu H; Yao X
    Biochim Biophys Acta; 2012 Feb; 1820(2):116-23. PubMed ID: 22155634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
    Leliveld SR; Stitz L; Korth C
    Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward a mechanism of prion misfolding and structural models of PrP(Sc): current knowledge and future directions.
    Guest WC; Plotkin SS; Cashman NR
    J Toxicol Environ Health A; 2011; 74(2-4):154-60. PubMed ID: 21218344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversibility of prion misfolding: insights from constant-pH molecular dynamics simulations.
    Vila-Viçosa D; Campos SR; Baptista AM; Machuqueiro M
    J Phys Chem B; 2012 Aug; 116(30):8812-21. PubMed ID: 22803931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of the pathogenic conformational change of the prion protein by an attractor of low order.
    Havsteen BH
    J Theor Biol; 2004 Nov; 231(1):39-48. PubMed ID: 15363928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring structural and thermodynamic stabilities of human prion protein pathogenic mutants D202N, E211Q and Q217R.
    Guo J; Ren H; Ning L; Liu H; Yao X
    J Struct Biol; 2012 Jun; 178(3):225-32. PubMed ID: 22491059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
    Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
    J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing the denatured state of human prion 121-230.
    Lee CI; Chang NY
    Biophys Chem; 2010 Sep; 151(1-2):86-90. PubMed ID: 20627399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirements for mutant and wild-type prion protein misfolding in vitro.
    Noble GP; Walsh DJ; Miller MB; Jackson WS; Supattapone S
    Biochemistry; 2015 Feb; 54(5):1180-7. PubMed ID: 25584902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into structural properties of denatured human prion 121-230 at melting temperature studied by replica exchange molecular dynamics.
    Tang JL; Wu PJ; Wang SC; Lee CI
    J Phys Chem B; 2012 Mar; 116(10):3305-12. PubMed ID: 22339436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular modelling indicates that the pathological conformations of prion proteins might be beta-helical.
    Downing DT; Lazo ND
    Biochem J; 1999 Oct; 343 Pt 2(Pt 2):453-60. PubMed ID: 10510313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constant-pH molecular dynamics simulations reveal a β-rich form of the human prion protein.
    Campos SR; Machuqueiro M; Baptista AM
    J Phys Chem B; 2010 Oct; 114(39):12692-700. PubMed ID: 20843095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational conversion of prion protein in prion diseases.
    Zhou Z; Xiao G
    Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):465-76. PubMed ID: 23580591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing misfolding of the prion protein by trimethylamine N-oxide.
    Bennion BJ; DeMarco ML; Daggett V
    Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the structural stability of rabbit prion probed by molecular dynamics simulations.
    Zhang J
    J Biomol Struct Dyn; 2009 Oct; 27(2):159-62. PubMed ID: 19583441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One gene, two diseases and three conformations: molecular dynamics simulations of mutants of human prion protein at room temperature and elevated temperatures.
    Shamsir MS; Dalby AR
    Proteins; 2005 May; 59(2):275-90. PubMed ID: 15739202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.